BioCentury
ARTICLE | Company News

Celera Genomics Group, Institut de Recherche Pierre Fabre deal

January 29, 2001 8:00 AM UTC

Using patients enrolled in clinical trials at the institute, CRA will study DNA variations in tubulin genes and other genes to understand their role in the efficacy and side effects of drugs used to ...